Clinical Trials for Innate Pharma

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Innate Pharma

Clinical Trials (7)

NCT06781983
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
PHASE1Recruiting
105 participants
Started: Jan 24, 2025 · Completed: Apr 30, 2029
1 condition1 sponsor7 locations
NCT06088654
Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Recruiting
184 participants
Started: Mar 4, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor14 locations
NCT05742607
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
PHASE2Recruiting
70 participants
Started: Jun 23, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor30 locations
NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
PHASE1Recruiting
27 participants
Started: Jan 21, 2022 · Completed: Feb 28, 2026
9 conditions2 sponsors1 location
NCT04984837
Study of Lacutamab in Peripheral T-cell Lymphoma
PHASE2Recruiting
56 participants
Started: Oct 5, 2021 · Completed: Jan 30, 2028
2 conditions2 sponsors64 locations
NCT04590963
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
PHASE3Active, not recruiting
370 participants
Started: Oct 2, 2020 · Completed: Sep 24, 2025
1 condition2 sponsors127 locations
NCT03902184
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma
PHASE2Active, not recruiting
170 participants
Started: May 22, 2019 · Completed: Jan 31, 2026
3 conditions1 sponsor53 locations